Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
TTAIKO PHARMACEUTICAL CO.,LTD. logo
4574TSE Prime

TAIKO PHARMACEUTICAL CO.,LTD.

大幸薬品 Yahoo Finance

Recent & upcoming events

Aug 13
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 14
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 26
Shareholder meeting 21:00
Shareholders' meeting
Venue: オリックス本町ビル 3階「大会議室」, 大阪市西区西本町一丁目4番1号 Details
Add to Google Calendar
Feb 13
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 12
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Dec 27
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Dec 28
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
2027
Feb 11
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 13
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Jun 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Jun 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Aug 5
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥6.40B YoY +1.7%
Operating income ¥459M margin 7.2%
Net income ¥923M YoY +2.8%
EPS ¥18 YoY +2.7%
P/E —
ROE 11.2% Equity ratio 69% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2026/12 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥7.20B +12.6%
Operating income ¥500M +8.9%
Net income ¥550M -40.4%
EPS ¥11 -40.4%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue ¥1.93B¥1.70B¥1.38B¥1.48B——
Operating income ¥-47M¥-562M¥215M¥267M——
Net income ¥-48M¥-3.05B¥472M¥292M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2020–2025）

事業法人 5.6%国内機関 6.8%海外機関 18.3%個人 19.6%未開示 49.7%202020212022202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 6.8%日本マスタートラスト信託銀行株式会社（信託口）柴田　高 6.6%柴田　高柴田　仁 6.6%柴田　仁ZONGYI SOLAR POWER 4.2%ZONGYI SOLAR POWER(LUXEMBOURG)（常任代理人　シティバンク、エヌ・エイ東京支店）柴田　晃宏 3.8%柴田　晃宏興和株式会社 3%興和株式会社柴田　穣 2.7%柴田　穣アース製薬株式会社 2.6%アース製薬株式会社202020212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
ROYAL BANK OF CANADA SINGAPORE BRANCH-CLIENT’S A/C 3,852,765 7.7% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社（信託口） 3,426,100 6.8% Yuho (EDINET)
柴田 高 3,330,431 6.6% Yuho (EDINET)
柴田 仁 3,298,810 6.6% Yuho (EDINET)
NOMURA SINGAPORE LIMITEDCUSTOMER SEGREGATED A/C FJ-1309 3,185,900 6.3% Yuho (EDINET)
ZONGYI SOLAR POWER(LUXEMBOURG) 2,129,400 4.2% Yuho (EDINET)
柴田 晃宏 1,899,445 3.8% Yuho (EDINET)
興和株式会社 1,508,000 3.0% Yuho (EDINET)
柴田 穣 1,336,054 2.7% Yuho (EDINET)
アース製薬株式会社 1,311,400 2.6% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 7.5%
✓ Positive operating cash flow ¥814M
✓ ROA improved YoY 7.0% → 7.5%
✗ Operating CF exceeds net income (accrual quality) OCF ¥814M / net income ¥923M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 61.7% → 69.4%
✓ Current ratio improved 3.07× → 3.36×
✓ No dilution (shares outstanding did not increase) 50,636,900 → 50,636,900
✗ Gross margin improved 58.3% → 54.4%
✓ Asset turnover improved 0.49× → 0.52×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 69.4%
Current ratio 3.4×
Years of positive operating CF 4 of last 9 yrs
Payout ratio 21%
Latest fiscal year result Profit (net income ¥923M)

Performance history

Last 10 years
0億円44億円88億円132億円176億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 82.994.610417611350.461.262.964.0
Operating income 15.518.620.356.5-49.5-30.8-10.16.294.59
Ordinary income 14.115.718.954.5-61.3-33.5-12.56.884.82
Net income 10.510.914.238.5-95.9-49.0-36.18.989.23
Total assets 188205216318225150132129123
Equity 15416417522812880.467.479.685.2

Indicators & cash flow

*Split-adjustedUnit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS ¥25¥26¥33¥89¥-221¥-112¥-76¥18¥18
ROE 7.4%6.9%8.4%18.3%-53.9%-47.0%-48.9%12.2%11.2%
Operating CF 27.0-0.6017.5-15.2-16.0-19.9-3.073.628.14
Investing CF -0.72-1.14-7.47-27.6-16.21.9011.7-0.051.42
Financing CF 12.5-0.74-3.38-6.4939.6-9.9715.4-11.8-12.3
FCF 26.3-1.7310.0-42.8-32.2-18.08.593.579.56

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data